TSRI
News
Structure
Solved by Scientists at TSRI Marks Important Milestone in
Effort to Develop HIV Vaccine
Scientists working at The Scripps Research Institute (TSRI)
and the Glycobiology Institute at Oxford University in the
United Kingdom have published the structure of an antibody
that effectively neutralizes human immunodeficiency virus
(HIV). The authors hope that this structure will provide a
basis for the design of effective vaccines against the HIV
virus.
Generous
Gifts Make Possible the First Norton B. Gilula Fellowships
and 11 Other Merit Awards for TSRI Graduate Students
Thirteen graduate students will receive 2001-2002 merit-based
awards, which include the first Norton B. Gilula Fellowships.
TSRI
Investigator Receives Leukemia and Lymphoma Society Award
Associate Professor Wendy Havran is being awarded the Stohlman
Scholar Award from the Leukemia and Lymphoma Society.
Snapshot:
Matt Barnas
Meet Senior Systems Analyst Matt Barnas, a.k.a. "one of the
Mac guys."
|
TSRI investigator Ben Cravatt's research on the fatty acid
amide hydrolase (FAAH) holds out promise for suggesting a
way to alleviate pain with few side effects.
|
